
Medexus Pharmaceuticals
(TSX) MDP
Medexus Pharmaceuticals Financials at a Glance
Market Cap
CA$130.49M
Revenue (TTM)
$99.33M
Net Income (TTM)
-$2.39M
EPS (TTM)
-CA$0.10
P/E Ratio
-244.85
Dividend
CA$0.00
Beta (Volatility)
0.93 (Low)
Dividend
CA$0.00
Beta (Volatility)
0.93 (Low)
Price
CA$4.20
Volume
79,286
Open
CA$4.04
Price
CA$4.20
Volume
79,286
Open
CA$4.04
Previous Close
CA$4.20
Daily Range
CA$3.94 - CA$4.29
52-Week Range
CA$2.47 - CA$4.29
Estimated Earnings Date
Aug 18, 2026
Dividend
CA$0.00
Beta (Volatility)
0.93 (Low)
Price
CA$4.20
Volume
79,286
Open
CA$4.04
Previous Close
CA$4.20
Daily Range
CA$3.94 - CA$4.29
52-Week Range
CA$2.47 - CA$4.29
Estimated Earnings Date
Aug 18, 2026
MDP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Medexus Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
90
CEO
Kenneth d’Entremont
Website
www.medexus.comHeadquarters
Toronto, ON M5C 1C3, CA
MDP Financials
Key Financial Metrics (TTM)
Gross Margin
54.78%
Operating Margin
5.18%
Net Income Margin
-2.41%
Return on Equity
-4.64%
Return on Capital
8.19%
Return on Assets
-1.63%
Earnings Yield
-0.41%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
CA$130.49M
Shares Outstanding
32.30M
Volume
79.29K
Avg. Volume
47.75K
Financials (TTM)
Gross Profit
$54.41M
Operating Income
$5.14M
EBITDA
$12.59M
Operating Cash Flow
$18.87M
Capital Expenditure
-$15.15M
Free Cash Flow
$3.72M
Cash & ST Invst.
$6.52M
Total Debt
$22.26M
Medexus Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$24.65M
-0.4%
Gross Profit
$13.27M
+6.8%
Gross Margin
53.84%
N/A
Market Cap
CA$130.49M
N/A
Market Cap/Employee
CA$1.43M
N/A
Employees
91
N/A
Net Income
-$2.68M
-383.7%
EBITDA
$475.00K
-87.1%
Quarterly Fundamentals
Total Cash
$6.52M
-72.8%
Total Debt
$22.26M
-40.1%
Accounts Receivable
$14.86M
+11.7%
Inventory
$33.30M
-5.6%
Long Term Debt
$20.05M
+10026.8%
Short Term Debt
$2.21M
-94.0%
Return on Assets
-1.63%
N/A
Return on Invested Capital
5.49%
N/A
Free Cash Flow
-$11.22M
-604.5%
Operating Cash Flow
$3.79M
+66.4%